FREIRE TORRES RUSSO; Valter

Patent Applications and Registrations

Patent applications and USPTO patent grants for FREIRE TORRES RUSSO; Valter.The latest application filed is for "compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors".

Company Profile

3.6.9

FREIRE TORRES RUSSO; Valter - Itapira BR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds And Pharmaceutical Compositions For Treating Disorders Associated With The 5-ht1a And 5-ht2a Receptors App 20210338674 - FREIRE TORRES RUSSO; Valter ; et al.	2021-11-04
Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders Grant 11,091,445 - Ruch Werneck Guimaraes , et al. August 17, 2	2021-08-17
Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders Grant 10,781,182 - Ruch Werneck Guimaraes , et al. Sept	2020-09-22
Compounds, Process For Obtaining The Compounds, Pharmaceutical Composition, Use Of The Compounds And Method For Treating Psychia App 20200277265 - RUCH WERNECK GUIMAR ES; Cristiano ; et al.	2020-09-03
Compounds, Process For Obtaining The Compounds, Pharmaceutical Composition, Use Of The Compounds And Method For Treating Psychia App 20190270711 - RUCH WERNECK GUIMAR ES; Cristiano ; et al.	2019-09-05
Compounds and pharmaceutical compositions for treating disorders associated with the 5-HT1A and 5-HT2A receptors Grant 9,326,984 - Freire Torres Russo , et al. May 3, 2	2016-05-03
Compounds And Pharmaceutical Compositions For Treating Disorders Associated With The 5-ht1a And 5-ht2a Receptors App 20160008360 - FREIRE TORRES RUSSO; Valter ; et al.	2016-01-14
Compounds and pharmaceutical compositions for treating disorders associated with the 5-HT1A and 5-HT2A receptors Grant 9,169,218 - Freire Torres Russo , et al. October 27, 2	2015-10-27
Method of Treatment of Anxiety Disorder Comorbid with Depression Disorder App 20150018365 - FREIRE TORRES RUSSO; Valter ; et al.	2015-01-15
Compounds and Pharmaceutical Compositions for Treating Disorders Associated With the 5-HT1A and 5-HT2A Receptors App 20140336199 - FREIRE TORRES RUSSO; Valter ; et al.	2014-11-13
Compounds and Pharmaceutical Compositions for Treating Disorders Associated With the 5-HT1A and 5-HT2A Receptors App 20140303179 - FREIRE TORRES RUSSO; Valter ; et al.	2014-10-09
Compounds and pharmaceutical compositions for treating disorders associated with the 5-HT1A and 5-HT2A receptors Grant 8,735,578 - Freire Torres Russo , et al. May 27, 2	2014-05-27
Compounds And Pharmaceutical Compositions For Treating Disorders Associated With The 5-ht1a And 5-ht2a Receptors App 20130184286 - Freire Torres Russo; Valter ; et al.	2013-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.